Clinical Trial Update: Re-Read Study to Compare the Brain Uptake of [18F]Flutemetamol With Brain Neuritic Plaque Density Determined Postmortem

View source ↗

Summary

This update describes the Re-Read study evaluating the brain uptake of [18F]Flutemetamol against brain neuritic plaque density measured postmortem. The trial, s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Drugs mentioned

• VIZAMYL (Flutemetamol F-18)

Snippet

Sponsor: GE Healthcare | Conditions: Cognitive Impairment | Status: COMPLETED | Results posted: 2014-08-27